Jazwares Cares Celebrates Squishmallows Day With Largest Single Squishmallows Donation to Charities Worldwide
7.3.2025 12:00:00 CET | Business Wire | Press release
Hundreds of Thousands of Children Will Receive Squishmallows through Hospitals, Schools, and Non-Profit Organizations
To celebrate the third-annual Squishmallows Day on Friday, March 7, Jazwares Cares, the philanthropic arm of global toy company Jazwares, is thrilled to announce that the largest single Squishmallows donation ever will be given to children and families in need across the U.S., Europe and Australia.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250307969506/en/
Jazwares Cares Celebrates Squishmallows Day with Squishmallows Donation (Photo: Business Wire)
“Putting a smile on children’s faces is at the heart of everything we do,” said Laura Zebersky, President and Chief Commercial Officer for Jazwares. “As Squishmallows continues to capture the hearts of fans around the world, what better way to celebrate the third-annual Squishmallows Day than to bring joy to kids who may not have Squishmallows of their own with our largest single Squishmallows donation.”
Paying it forward to all its fans, more than 500,000 loveable, huggable Squishmallows plush will be distributed through children’s hospitals, Title I schools, and Jazwares Cares’ non-profit partners. In the U.S., Jazwares Cares is partnering with The Toy Foundation, Baby2Baby, Toys for Tots, First Responders Children’s Foundation, and more. In Australia, Jazwares is working with the Australian Toy Industry to donate Squishmallows to Backpacks 4 VIC Kids. In Europe, Jazwares will partner with charities In Kind Direct, Innatura, and Dons Solidaires, to provide Squishmallows to children and their families across the UK, Germany, and France respectively.
Jazwares Cares’ mission is to support children's health, well-being, and educational development through play. This is achieved through product donations, sponsorships, education-based programs, and the time and talent of Jazwares employees.
For more information on Jazwares, visit Jazwares on LinkedIn, X, Instagram, Facebook, and www.jazwares.com. For more information on Squishmallows, visit Squishmallows on X, Facebook, Instagram, TikTok, and Squishmallows.com.
ABOUT JAZWARES
Jazwares, a Berkshire Hathaway company, is a leading global toy manufacturer with a robust portfolio of owned and licensed brands. Founded in 1997, Jazwares celebrates imaginative play with a progressive focus on identifying new and relevant trends to transform into high-quality products for consumers of all ages. Jazwares engages consumers through innovative play experiences with popular brands such as Squishmallows™, Pokémon™, Hello Kitty™, Star Wars™, Disney™, BumBumz™, and Adopt Me™. In addition to toys, offerings include virtual games, costumes, and pet products. Headquartered in Plantation, Florida, Jazwares has offices worldwide and sells its products in over 100 countries. For more information, visit www.jazwares.com and follow us on LinkedIn, X, Instagram, and Facebook.
ABOUT SQUISHMALLOWS
Squishmallows debuted in 2017 and has since evolved into a lovable lifestyle brand for fans of all ages. Recent achievements have included 10 Toy of the Year Awards, partnerships with major corporations (H&M, Puma, McDonald’s), and continued fan engagement at events like VidCon Anaheim, San Diego Comic-Con, and the Squish Bus Tour that swept the nation in 2023. With line extensions into apparel and pet products, collaborations with studios like Netflix and Warner Bros., and our global licensing program featuring 90+ partners, Squishmallows looks forward to continuing to expand the Squad, one Squish at a time.
ABOUT SQUISHMALLOWS DAY
We unveiled our first-ever Squishmallows—the iconic Cam the Cat —on March 7th, 2017. The Squishmallows brand took the world by storm later that year, and the rest is history. Whether you’ve been with us from the beginning or are just joining the Squad now, one thing is certain: we couldn’t do it without you. Every year on March 7th, Squishmallows celebrates its growing community and dedicates this day to fans all around the world in the #SquishmallowsSquad.
This release contains disclosures that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as "may," "will," "expect," "project," "estimate," "anticipate," "plan," "believe," "potential," "should," "continue" or the negative versions of those words or other comparable words. These forward-looking statements are based upon Jazwares' current plans or expectations and are subject to a number of uncertainties and risks. These statements are not guarantees of future performance, and Jazwares has no specific intention to update these statements. As a consequence, current plans, and anticipated actions may differ from those expressed in any forward-looking statements made by Jazwares or on Jazwares’ behalf.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250307969506/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
DEWA Organises Second Agentic AI Retreat at Al Shera’a, World’s Tallest, Largest and Smartest Net‑Positive Government Building12.6.2026 17:08:00 CEST | Press release
HE Saeed Mohammed Al Tayer, MD & CEO of Dubai Electricity and Water Authority (DEWA),has emphasised that DEWA deploys the latest Agentic AI technologies, in line with the vision to enhance its leading role and reinforce Dubai’s position as the city of the future. He made these remarks during the Agentic AI Executive Retreat DEWA organised at Al Shera’a, its new headquarters, which is the world’s tallest, largest and smartest net-positive government building. The event was attended by the executive leadership team and key stakeholders in digital transformation and artificial intelligence (AI), as well as representatives from SAP and McKinsey. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612633834/en/ DEWA organises second Agentic AI Retreat at Al Shera’a, world’s tallest, largest and smartest net positive government building (Photo: AETOSWire) In his speech, Al Tayer said that DEWA is guided by directives from the wise l
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom